Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119472) titled 'Efficacy and safety analysis of Vericiguat in the treatment of acute heart failure patients: a multicenter, randomized controlled, open label clinical study (VERIFAST study)' on Feb. 27.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Shanghai Tenth People's Hospital
Condition:
acute heart failure
Intervention:
Control Group:GDMT Standard Heart Failure Treatment
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-03-06
Target Sample Size: Control Group:106;Experimental Group:106;
Countries of Recruitment:
China
To know more, visit https://www.chi...